Apollo Hospitals To Get Accreditation From Joint Commission International

Font Size

Print

Feedback

Email

Discuss

Related Articles

Max India approves JV with UK-based firm

Hyderabad, Aug 27: In what is believed to be the first among Indian hospitals, Apollo Hospitals is marching ahead to get the Joint Commission International (JCI) accreditation, an arm of the Illinois, the US-based Joint Commission on Accreditation of Healthcare Organisation (JCAHO). The healthcare accredition is being awarded following the stringent quality standards maintained by the hospital. Apollo Hospitals expects to get the first certificate in the next 12-18 months for its facility in Delhi.

Addressing the media on the occasion of its 16 anniversary, Dr Prathap C Reddy, chairman, Apollo Hospitals Group, said that this is the first of its kind of certificate to be awarded to any healthcare organisation in the country. Initially, the hospital is planning to get the accreditation in a phased manner, starting off for its Delhi hospital followed by Chennai and Hyderabad hospitals.

Explaining about another achievement - for the first time in Asia - Apollo Hospitals, Hyderabad, in association with the Gleneagles group of Singapore is bringing a new imaging device with 50:50 investment to enhance diagnostic and therapeutic efficacy in oncology, cardiology and neurosciences. The new imaging device is called the PET-CT scan costing about Rs 26 crore. PET-CT scan is being presently installed and will be functional in the next couple of weeks, Dr Reddy said.

He said with the new device, about 30 patients can be scanned with a price tag of about Rs 25,000 for each patient. The scan will reduce the number of chemotherapies and radiation treatments which are required by the cancer patients at different intervals. PET-CT scan is a revolutionary diagnostic medical imaging device which can produce a biograph - an image which can record in detail - living tissues and life processes. The instrument sets the target for enhanced oncology disease management by reducing the number of diagnostic tests and improved therapy planning for cancer patients.

Apart from oncology, PET-CT scan is an useful non-invasive diagnostic option for cardiologists especially for critical people and in neurosciences for a definitive advantage from all other diagnostic options, Dr Reddy added.